Global Clinical Trial Imaging Market Size By Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound), By End User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturers), By Geographic Scope And Forecast
Published Date: August - 2024 | Publisher: MIR | No of Pages: 320 | Industry: latest updates trending Report | Format: Report available in PDF / Excel Format
Global Clinical Trial Imaging Market Size By Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound), By End User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturers), By Geographic Scope And Forecast
Clinical Trial Imaging Market Size And Forecast
Clinical Trial Imaging Market size was valued at USD 963 Million in 2020 and is projected to reach USD 1,518 Million by 2028, growing at a CAGR of 5.9% from 2021 to 2028.
The Global Clinical Trial Imaging Market is expected to witness significant growth during the forecast period due to increased spending for research and development, and an increasing number of pharmaceutical and biotechnological industries. The Global Clinical Trial Imaging Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Clinical Trial Imaging Market Definition
A clinical trial is an important part of the drug development process. However, the cost of conducting clinical trials has increased in past few years. Therefore, clinical trial imaging is emerging as an alternative measure that will help reduce the cost of the drug trial as well as will improve the timeline of clinical trials.
Global Clinical Trial Imaging Market Overview
Medical imaging plays an important role in the clinical development of novel life science products. Although the medical imaging industry is in a constant state of fluctuation, the biotechnology, as well as pharmaceutical industries, continue to increase. This is attributed to enhanced investment in medical imaging companies as well as mergers and acquisitions along with the adoption of innovative imaging technologies to support clinical trials for medical devices. However, the high cost of machinery, their installation, and the high capital required to run clinical trials will restrain the growth of the market.
Advancements in technology are enabling substantial improvements in the collection, evaluation, as well as submission of clinical trial imaging data. Technology-enabled imaging, especially image analysis software, offers numerous benefits such as data accuracy, consistency, adaptability, and compliance, to clinical studies. For instance, image analysis software is implemented to manage and direct a reader via analysis of imaging time points.
The increasing use of technology along with the enhanced power of computing is boosting the use of imaging in clinical trials. The Quantitative Imaging Biomarkers Alliance (QIBA) protocol offers standardized methods as well as imaging procedures with uniform procedures that can be implemented to attain precise as well as statistical endpoints in clinical trials.
Global Clinical Trial Imaging Market Segmentation Analysis
The Global Clinical Trial Imaging Market is segmented on the basis of Modality, End User, And Geography.
Clinical Trial Imaging Market, By Modality
Computed Tomography
Magnetic Resonance Imaging
Ultrasound
Positron Emission Tomography
X-Ray
Echocardiography
Other Modalities
Based on Modality, the market is segmented into Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-Ray, Echocardiography, and Other Modalities. Computed tomography is a non-invasive medical procedure that uses X-Ray to generate cross-sectional images of the body. CT scan provides detailed information to plan treatment as well as examine abnormalities in children and adults. Radiological imaging combined with specific molecular assays acts as a valuable tool to help in the go and no-go decision in preclinical as well as clinical settings.
Clinical Trial Imaging Market, By End User
Pharmaceutical Companies
Biotechnology Companies
Medical Device Manufacturers
Contract Research Organizations
Academic and Government Research Institutes
Other End-Users
Based on End-User, the market is bifurcated into Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturers, Contract Research Organizations, Academic and Government Research Institutes, and Other End-Users. Snowballing the cost of drug development along with increased research and development activities is contributing to the growth of the segment. Contract research outsourcing collaborations also offer several cutting-edge services. Therefore, government organizations always prefer the handover of projects to CROs.
Clinical Trial Imaging Market, By Geography
North America
Europe
Asia Pacific
Rest of the World
Based on regional analysis, the Global Clinical Trial Imaging Market is classified into North America, Europe, Asia Pacific, and Rest of the world. The Asia Pacific is anticipated to experience the highest growth during the forecast period. The increasing incidence of chronic diseases, as well as the growing need for better diagnostic devices, are stimulating the growth of the regional market. Apart from this, the surging demand for specialized and quality healthcare facilities to improve patient’s life will also boost the overall market growth.
Key Players
The “Global Clinical Trial Imaging Market” study report will provide a valuable insight with an emphasis on the global market. The major players in the market are Parexel International Corporation, Biomedical Systems Corporation, Biotelemetry, Inc., Cardiovascular Imaging Technologies LLC, Intrinsic Imaging LLC, Radiant Sage LLC, and Worldcare Clinical, LLC. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Key Developments
On January 2021, Bioclinica, an integrated solutions provider of clinical life science and technology expertise, announced the release of Image Redact AI, a new product that will support the redaction of sensitive patient information from videos, photos, as well as PDFs in clinical trials.
On December 2020, The merger of ERT and Bioclinica will create a global leader in clinical trial endpoint technology. The transaction will combine Bioclinica’s imaging expertise with ERT’s expertise in eCOA, cardiac safety, respiratory, as well as wearables.
Report Scope
REPORT ATTRIBUTES
DETAILS
STUDY PERIOD
2017-2028
BASE YEAR
2020
FORECAST PERIOD
2021-2028
HISTORICAL PERIOD
2017-2019
UNIT
Value (USD Million)
KEY COMPANIES PROFILED
Parexel International Corporation, Biomedical Systems Corporation, Biotelemetry, Inc., Cardiovascular Imaging Technologies LLC, Intrinsic Imaging LLC.
SEGMENTS COVERED
By Modality
By End User
By Geography
CUSTOMIZATION SCOPE
Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope
Top Trending Reports
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly
Reasons to Purchase this Report
Understanding the Market Inside and Out We'll dive into the market, uncovering its unique characteristics and behaviors from all angles. We'll consider people's incomes, interests, and even their values to paint a complete picture of what drives the market. Mapping the Market's Value We'll quantify the market's worth, showing you exactly how much money is circulating in each part of it. We'll zoom in on t?ng phân khúc, giving you a clear understanding of where the big bucks are. Pinpointing Growth Hotspots We'll predict which parts of the market are about to take off and dominate the competition. We'll identify the regions and segments that are ready to explode, so you can stay ahead of the curve. Exploring the Regional Landscape We'll journey across regions, examining how people in different parts of the world buy and use this product or service. We'll dig into the local factors that shape the market and influence its success. Sizing Up the Competition We'll introduce you to the major players in the market, ranking them according to their size and influence. We'll track their moves over the past five years, noting new products, partnerships, and acquisitions. Profiling Market Leaders We'll provide detailed profiles of the top players, giving you an inside look at their strengths, weaknesses, and strategies. We'll also benchmark their products and services to help you make informed choices. Gazing into the Market's Future We'll forecast the market's trajectory, considering current trends and potential disruptions. We'll identify opportunities for growth and obstacles to overcome, giving you a roadmap for success in both rising and established markets. Analyzing Market Forces We'll use Porter's Five Forces analysis to dissect the market dynamics, revealing the factors that shape competition, profitability, and industry attractiveness. Understanding the Value Chain We'll trace the steps involved in bringing this product or service to market, uncovering the key activities and players in the process. Visualizing Market Trends We'll illustrate our findings with charts and graphs, making it easy for you to understand the market's dynamics and spot emerging opportunities. Staying Informed We'll provide ongoing support for six months, keeping you updated on market developments and answering any questions you may have.
Customization of the Report
• In case of anyplease connect with our sales team, who will ensure that your requirements are met.
For a single, multi and corporate client license, the report will be available in PDF format.
Sample report would be given you in excel format. For more questions please contact:
Sample Report for Global Clinical Trial Imaging Market Size By Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound), By End User (Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturers), By Geographic Scope And Forecast